Progress of immunotherapy in the treatment of malignant melanoma.
作者信息
Ariyan S
出版信息
Yale J Biol Med. 1975 Nov;48(5):423-9.
Abstract
摘要
相似文献
1
Progress of immunotherapy in the treatment of malignant melanoma.免疫疗法在恶性黑色素瘤治疗中的进展
Yale J Biol Med. 1975 Nov;48(5):423-9.
2
[Immunology of melanoma].[黑色素瘤的免疫学]
Acta Chir Belg. 1974 Mar;73(2):135-88.
3
[Development in the immunotherapy of malignant melanoma].[恶性黑色素瘤免疫治疗的进展]
Hautarzt. 1976 Jan;27(1):1-7.
4
Immunological studies on malignant melanomas of man.人类恶性黑色素瘤的免疫学研究。
Yale J Biol Med. 1973 Dec;46(5):693-701.
5
[Immunological aspects of melanoma].[黑色素瘤的免疫学方面]
Lakartidningen. 1976 Feb 11;73(7):528-30.
6
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.卡介苗治疗恶性黑色素瘤的细胞介导免疫体外测定：初步报告。
Natl Cancer Inst Monogr. 1973 Dec;39:221-4.
7
Immune response and non-specific immunotherapy in melanoma.黑色素瘤中的免疫反应与非特异性免疫疗法
Ann R Coll Surg Engl. 1978 Mar;60(2):117-20.
8
9
10
Immunotherapy and immune competence of patients with malignant melanoma.恶性黑色素瘤患者的免疫治疗与免疫能力
Czech Med. 1983;6(3):172-4.
引用本文的文献
1
Infection of DBA/2 or C3H/HeJ mice by intraperitoneal injection of vaccinia virus elicits activated macrophages, cytolytic and cytostatic for S91-melanoma tumor cells.通过腹腔注射痘苗病毒感染DBA/2或C3H/HeJ小鼠，可引发对S91黑色素瘤肿瘤细胞具有细胞溶解和细胞抑制作用的活化巨噬细胞。
Cancer Immunol Immunother. 1986;22(3):197-203. doi: 10.1007/BF00200033.
本文引用的文献
1
Role of nonimmunized macrophages in the rejection of an allotransplanted lymphoma.未免疫巨噬细胞在同种异体移植淋巴瘤排斥反应中的作用。
J Natl Cancer Inst. 1970 Mar;44(3):739-49.
2
Immunological factors which influence response to immunotherapy in malignant melanoma.影响恶性黑色素瘤免疫治疗反应的免疫因素。
Surgery. 1970 Jul;68(1):158-63; discussion 163-4.
3
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.有提示性证据表明，荷瘤个体的“封闭抗体”可能是抗原-抗体复合物。
Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372-5. doi: 10.1073/pnas.68.6.1372.
4
Clinical experiences in immunotherapy of cancer.癌症免疫治疗的临床经验
Surg Gynecol Obstet. 1971 Aug;133(2):209-17.
5
Tumors of the skin. X. Immunotherapy of cutaneous and mucosal neoplasms.皮肤肿瘤。十、皮肤和黏膜肿瘤的免疫疗法。
N Y State J Med. 1968 Apr 1;68(7):900-11.
6
Immunological effects of BCG in malignant melanoma: two modes of administration compared.卡介苗在恶性黑色素瘤中的免疫效应：两种给药方式的比较
Ann Intern Med. 1972 Mar;76(3):405-11. doi: 10.7326/0003-4819-76-3-405.
7
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.癌症免疫疗法：经神经氨酸酶处理的肿瘤细胞加卡介苗受体中肿瘤的免疫特异性排斥反应
Science. 1971 Nov 5;174(4009):591-3. doi: 10.1126/science.174.4009.591.
8
Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages.非特异性免疫的巨噬细胞增强特异性肿瘤免疫的过继转移
J Natl Cancer Inst. 1973 Oct;51(4):1145-8. doi: 10.1093/jnci/51.4.1145.
9
BCG immunotherapy of malignant melanoma: summary of a seven-year experience.卡介苗免疫疗法治疗恶性黑色素瘤：七年经验总结
Ann Surg. 1974 Oct;180(4):635-43. doi: 10.1097/00000658-197410000-00029.
10
The limited role of attenuated smallpox virus in the management of advanced malignant melanoma.减毒天花病毒在晚期恶性黑色素瘤治疗中的有限作用。
Aust N Z J Surg. 1966 May;35(4):286-90. doi: 10.1111/j.1445-2197.1966.tb03889.x.
Zotero 插件